ANGIODROID

Angiodroid uses through a dedicated automatic injector, CO2 (a natural gas, biocompatible for humans) to drastically reduce Contrast Induced Nephropathy, a leading cause for kidney failure in patients during hospitalisation, preserving the renal function of thousands of patients, every year.

2021 SIT finalist

Angiodroid applies a dedicated automatic injector using CO2 (a natural gas, biocompatible for humans) to drastically reduce contrast-induced nephropathy, a leading cause of kidney failure in patients during hospitalisation, preserving the renal functions of thousands of patients every year.

Sectors: Health

Country: Italy

Country(s) of implementation: Germany, France, Italy, United Kingdom, Spain

Contact and social media

Angiodroid
Angiodroid
@Angiodroid
info@angiodroid.com

Link to WeChangers: https://wechangers.org/en/organizations/18895